Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
Clinical trial NCT05413356 · UNKNOWN
Trial details
- NCT number
- NCT05413356
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.